Establishing and strengthening a national registry of congenital heart diseases in Iran: A policy brief

Sadatinejad, Seyyed Mohsen; Taghadosi, Mohsen

doi:10.48307/FMSJ.2025.29.S.720

[Home ] [Archive]

[ فارسی ]

Main Menu

Home

Journal Information

Indexing Sources

Guide for Authors

Online Submission

Ethics

Articles archive

For Reviewers

Contact us

Basic and Clinical Biochemistry and Nutrition

DOAJ

CINAHL

EBSCO

IMEMR

ISC

Search in website

Receive site information

enamad

Volume 29, Issue 7 (Special Issue 2025)

Feyz Med Sci J 2025, 29(7): 720-727

Back to browse issues page

Establishing and strengthening a national registry of congenital heart diseases in Iran: A policy brief

Seyyed Mohsen Sadatinejad

, Mohsen Taghadosi ^*

Trauma Nursing Research Center, Kashan University of Medical Sciences, Kashan, Iran , Taghadosi_m@KAUMS.AC.ir

Abstract: (207 Views)

Congenital heart disease (CHD) stands as the most prevalent congenital anomaly and ranks among the leading causes of infant mortality in Iran. Although substantial progress has been achieved in diagnostic and therapeutic approaches, the lack of a comprehensive, integrated, nationwide system for registering and monitoring patients with CHD remains a major barrier to evidence-based health planning, equitable resource allocation, and effective evaluation of treatment outcomes.
This policy brief elucidates the scale of the problem, highlights existing structural and informational deficiencies, and examines the current fragmented methods of CHD data collection within the country. It reviews successful domestic experiences with regional registries, including the PROVE/CHD registry in Isfahan and the TRoCA registry in Tabriz, and draws practical lessons from these models. The brief further presents actionable recommendations for policymakers, health system managers, healthcare providers, and the research community, emphasizing the establishment and sustained support of a standardized and unified national CHD registry. Such a registry would ensure systematic patient data capture, facilitate long-term follow-up, and foster the generation of high-quality national evidence.
The overarching goal is to develop a sustainable, technology-based framework that facilitates accurate data collection, improves equity in access to specialized care, strengthens quality improvement initiatives, and enhances evidence-informed decision-making across the Iranian health system. For the sustainable implementation of a national CHD registry within Iran’s healthcare system, the most rational approach is to adopt a phased, hybrid model. The initial phase should focus on the accurate collection of data in specialized centers, followed by the gradual integration of additional outpatient clinics and administrative/claims data in subsequent phases. The success of this multi-source registry approach would require policy support, insurance incentives, and mandatory participation of clinical centers.

Keywords: Congenital heart disease, Children, Registry, Health policy, Policy brief

Full-Text [PDF 359 kb] (37 Downloads)

Type of Study: Policy Brief | Subject: medicine, paraclinic
Received: 2025/12/20 | Revised: 2026/04/26 | Accepted: 2026/01/18 | Published: 2026/03/15

References

1. Khaleghnejad Tabari A, Dastgiri S, Soori H, Ansari-Moghaddam A, Ghaem H, Latifi S, et al. Epidemiology of Congenital Anomalies in Iran. Iran J Surg. 2024; 32(Autumn):13-21.

2. Shahmansouri N, Kamali A, Dehbozorgi S, Delpak A, Mirzaaghayan MR, Dehghani S, et al. Disease Burden in Caregivers of Children with Congenital Heart Disease in Children's Medical Center, Tehran, Iran. J Iran Med Counc. 2023; 6(1): 45-51. doi:10.18502/jimc.v6i1.11841

3. Taghadosi M, Aliakbarzade AZ, Gilasi HR. Quality of life in patients with ischemic heart disease. 2014. doi:10.18869/acadpub.jnms.1.1.19

4. Mottaghi Moghaddam Shahri H, Salehi S, Yaghoobkhani S, Abbasi Tashnizi M, Tayyebi M, Moaven Zadeh NS, et al. Pediatric Arrhythmia Management in Congenital Heart Disease (CHD): A 20-Year Epidemiologic Study and Therapeutic Insights at Imam-Reza Hospital (2001-2020). Razavi J Med. 2025; 13(4):46-55.

5. Kalani M, Mahdikhoshouei F, Bahrami P, Khajouei AS, Movahedi M, Mehdipour S, et al. Designing a Software for Registry of Pregnant Women with Heart Disease in Iran and Preliminary Results. J Med Signals Sens. 2025;15(7):21. doi:10.4103/jmss.jmss_43_24 PMid:40777138 PMCid:PMC12331175

6. Ahmadi AR, Sabri MR, Navabi ZS, Ghaderian M, Dehghan B, Mahdavi C, et al. Early results of the Persian registry of cardiovascular disease/congenital heart disease (PROVE/CHD) in Isfahan. J Tehran Univ Heart Cent. 2020; 15(4):158. doi:10.18502/jthc.v15i4.5941 PMid:34178084 PMCid:PMC8217188

7. Hassankiadeh RF, Dobson A, Rahimi S, Jalilian A, Schmid VJ, Mahaki B. Spatial distribution and birth prevalence of congenital heart disease in Iran: a systematic review and hierarchical Bayesian meta-analysis. Int J Health Policy Manag. 2024;13:7931. doi:10.34172/ijhpm.2024.7931 PMid:39099509 PMCid:PMC11270618

8. Salari N, Faryadras F, Shohaimi S, Jalili F, Hasheminezhad R, Babajani F, et al. Global prevalence of congenital heart diseases in infants: A systematic review and meta-analysis. J Neonatal Nurs. 2024;30(6):570-5. doi:10.1016/j.jnn.2024.05.003

9. Dastgiri S. Congenital Anomalies in Iran: Springer; 2024. doi:10.1007/978-981-97-6274-3

10. Parvar SY, Ghaderpanah R, Naghshzan A. Prevalence of congenital heart disease according to the echocardiography findings in 8145 neonates, multicenter study in southern Iran. Health Sci Rep. 2023; 6(4):e1178. doi:10.1002/hsr2.1178 PMid:37033389 PMCid:PMC10073012

11. Siabani H, Siabani S, Gholizadeh L. Epidemiology of congenital heart defects in Iran: a systematic review. J Cardiol Res Rev Rep. 2019; 2(3):10.33552.doi:10.33552/OJCR.2019.02.000537

12. Taghadosi M, Memarian R, Ahmadi F. Life associated with fear and worry: A major concern among the cardiac valve-replaced patients. Iran J Nurs Midwifery Res. 2015;20(1).

13. Taghadosi M, Memarian R, Ahmadi F. The experiences of "difficult life" in heart valve replaced patients. Iran Red Crescent Med J. 2014; 16(8): e19147.doi:10.5812/ircmj.19147

14. Talebi T, Mohsen-Pour N, Hesami M, Maleki M, Kalayinia S. The association between in vitro fertilization and intracytoplasmic sperm injection treatment and the risk of congenital heart defects. J Matern Fetal Neonatal Med. 2022;35(25):7471-85. doi:10.1080/14767058.2021.1949705 PMid:34233556

15. Borjali M, Amini-Rarani M, Nosratabadi M. Nonmedical determinants of congenital heart diseases in children from the perspective of mothers: a qualitative study in Iran. Cardiol Res Pract. 2021; 2021(1):6647260. doi:10.1155/2021/6647260 PMid:34447593 PMCid:PMC8384533

16. Taghadosi M, Javadi N, Dianati M. Why do patients with ischemic heart disease modify their lifestyle? a qualitative study. BMC Res Notes. 2025; 18(1): 182.doi:10.1186/s13104-025-07169-4 PMid:40247372 PMCid:PMC12007254

17. Francis J, Peng E, Corno AF. Beyond borders: an appraisal of the global congenital cardiac surgery workforce. Transl Pediatr. 2024;13(6):897-907. doi:10.21037/tp-24-38 PMid:38984030 PMCid:PMC11228906

18. Khosravi A, Mansouri A, Shahsanayi F, Paydari N, Heshmat-Ghahdarijani K, Mansourian M, et al. Rationale and design of the Persian cardiovascular disease registry (PCVDR): Scale-up of Persian registry of CardioVascular DiseasE (PROVE). Curr Probl Cardiol. 2021;46(3):100577. doi:10.1016/j.cpcardiol.2020.100577 PMid:32359888

19. Molapour H, Dastgiri S, Esmaeili ED. Prevalence and time trend of congenital heart defects: a registry-based study in Iran. medRxiv. 2021:2021.12. 16.21267826. doi:10.1101/2021.12.16.21267826 PMid:33629102 PMCid:PMC8343565

20. Givi M, Heshmat-Ghahdarijani K, Garakyaraghi M, Yadegarfar G, Vakhshoori M, Heidarpour M, et al. Design and methodology of heart failure registry: results of the Persian registry of cardiovascular disease. Arya Atheroscler. 2019; 15(5):228.

21. Ephrem G. The Current State of the Board-Certified Adult Congenital Heart Disease Workforce 10 Years After Initial Certification. Am J Cardiol. 2025; 255:12-6. doi:10.1016/j.amjcard.2025.06.034 PMid:40614951

22. Pittrow RD, Dewald O, Harig F, Kaemmerer-Suleiman AS, Suleiman M, Pittrow LB, et al. Establishing a cardiology registry: navigating quality and regulatory challenges with a focus on congenital heart disease. Cardiovasc Diagn Ther. 2025; 15(2):455-64. doi:10.21037/cdt-2024-579 PMid:40385276 PMCid:PMC12082178

23. Malenka DJ, Bhatt DL, Bradley SM, Shahian DM, Draoui J, Segawa CA, et al. The national cardiovascular data registry data quality program 2020: JACC state-of-the-art review. J Am Coll Cardiol. 2022;79(17):1704-12. doi:10.1016/j.jacc.2022.02.034 PMid:35483759

24. Egbe AC, Miranda WR, Connolly HM. The Mayo Adult Congenital Heart Disease (MACHD) Registry and Biobank. JACC Adv. 2025; 4(8):102038. doi:10.1016/j.jacadv.2025.102038 PMid:40712266 PMCid:PMC12311493

25. Rezaie A, Taghadosi M, Molayi F, Asgarian FS, Raygan F, Sehat M. Cardiovascular complications in patients hospitalized with COVID-19: A cross-sectional study. J Nurs Adv Clin Sci. 2024;1(2):71-7. doi:10.32598/JNACS.2405.1024

26. Firoozjaei IT, Taghadosi M, Sadat Z. Determining the sexual quality of life and related factors in patients referred to the department of cardiac rehabilitation: A cross-sectional study. Int J Reprod Biomed. 2021;19(3):261-70. doi:10.18502/ijrm.v19i3.8574 PMid:33842823 PMCid:PMC8023004

27. Taghadosi M, Aghajani M, Ajorpaz NM. Intuitive decision-making by Iranian nurses of patients with COVID-19: a qualitative study. J Caring Sci. 2021;11(3):154. doi:10.34172/jcs.2022.04 PMid:36247041 PMCid:PMC9526789

28. Parker DM, Stabler ME, MacKenzie TA, Zimmerman MS, Shi X, Everett AD, et al. Population-Based Estimates of the Prevalence of Children with Congenital Heart Disease and Associated Comorbidities in the United States. Circ Cardiovasc Qual Outcomes. 2024;17(9):e010657. doi:10.1161/CIRCOUTCOMES.123.010657 PMid:39185543

29. Kumar SR, Goldstone AB, Heuerman H, Jacobs JP, O'Brien Jr JE, Pizarro C, et al. The Society of Thoracic Surgeons Congenital Heart Surgery Database: Update on Outcomes and Research. Ann Thorac Surg. 2025. doi:10.1016/j.athoracsur.2025.12.002

30. Marra C, Chico T, Alexandrow A, Dixon WG, Briffa N, Rainaldi E, et al. Addressing the challenges of integrating digital health technologies to measure patient-centred outcomes in clinical registries. Lancet Digit Health. 2025; 7(3):e225-e31. doi:10.1016/S2589-7500(24)00223-1 PMid:39672737

31. Pan J, Lee S, Cheligeer C, Li B, Wu G, Eastwood CA, et al. Assessing the validity of ICD-10 administrative data in coding comorbidities. BMJ Health Care Inform. 2025;32(1). doi:10.1136/bmjhci-2024-101381 PMid:40360294 PMCid:PMC12083369

32. Watanabe T, Ichinose Y, Toida T, Higashi T. Validity of patient-reported information: agreement rate between patient reports and registry data. BMC Health Serv Res. 2025;25(1):182. doi:10.1186/s12913-025-12324-5 PMid:39891116 PMCid:PMC11783825

33. Broughan JM, Wreyford B, Martin D, Melis G, Randall K, Obaro E, et al. Cohort profile: the National Congenital Anomaly Registration Dataset in England. BMJ Open. 2024;14(1):e077743. doi:10.1136/bmjopen-2023-077743 PMid:38216203 PMCid:PMC10806630

Send email to the article author

Add your comments about this article

‎ 10.48307/FMSJ.2025.29.S.720

Ethics code: 0000000000000000

Mendeley

Zotero

RefWorks

Sadatinejad S M, Taghadosi M. Establishing and strengthening a national registry of congenital heart diseases in Iran: A policy brief. Feyz Med Sci J 2025; 29 (7) :720-727
URL: http://feyz.kaums.ac.ir/article-1-5469-en.html

This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.

Volume 29, Issue 7 (Special Issue 2025)

Back to browse issues page

Persian site map - English site map - Created in 0.13 seconds with 46 queries by YEKTAWEB 4741